| FierceBiotech Executive Breakfast: Get Good Science and the Money will Follow
January 9 | 7:00-8:00am | The Fairmont | San Francisco
Biotech IPOs struggled until the second quarter of 2017, but investments through early raises in young biotechs reached major levels – with around half of 2016 Fierce15 winners seeing a $50M series A or B round in 2016 or 2017. Are we seeing a genuine reblooming of biomedical innovation, and is biotech, notably young biotech, ready to bring in the money, partners and investors needed to fuel R&D?
Speakers include:
• Katherine Bowdish, Ph.D., Vice President Global R&D and Head of Sunrise, Sanofi U.S.
• Arnon Rosenthal, Ph.D., CEO, Alector
• Jeremy M. Levin, D.Phil., MB BChir, Chairman of the Board of Directors and CEO, Ovid Therapeutics
• Alexis Borisy, Partner, Third Rock Ventures
• Andrew Allen, M.D., Ph.D., Co-founder, President and CEO, Gritstone Oncology
• Stephen Ubl, President and Chief Executive Officer, PhRMA
• Bernie Zeiher, President of Development, Astellas
Register today.
| 